Endpoints News | With CAR-T marketing looming, early study highlights potential of TCR engineering Endpoints News KITE-718 is already in the clinic, and it's been designed along the same TCR engineering that Rosenberg was trying out at the NIH. There are number of companies working on TCR therapies, including Adaptimmune $ADAP, which is closely allied with ... |